Cite

HARVARD Citation

    Gani, C. et al. (n.d.). In vivo studies of the PARP inhibitor, AZD-2281, in combination with fractionated radiotherapy: An exploration of the therapeutic ratio. Radiotherapy and oncology. 116 (3), pp. 486-494. [Online]. 
  
Back to record